Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-12-30

FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for bicalutamide by Accord Healthcare, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)